0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Aldult CAR T-cell Therapy Market Research Report 2026
Published Date: 2026-03-11
|
Report Code: QYRE-Auto-34G17559
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Aldult CAR T cell Therapy Market Research Report 2024
BUY CHAPTERS

Global Aldult CAR T-cell Therapy Market Research Report 2026

Code: QYRE-Auto-34G17559
Report
2026-03-11
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Aldult CAR T-cell Therapy Market

The global Aldult CAR T-cell Therapy market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The North American market for Aldult CAR T-cell Therapy is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Aldult CAR T-cell Therapy is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Aldult CAR T-cell Therapy in Multiple Myeloma is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Aldult CAR T-cell Therapy include Bristol Myers Squibb,BMS, Johnson & Johnson, Gilead Sciences, Novartis, JW Therapeutics, Imunopharm Technology Co., Ltd., CARsgen Therapeutics, Cartesian Therapeutics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Aldult CAR T-cell Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Aldult CAR T-cell Therapy. The Aldult CAR T-cell Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Aldult CAR T-cell Therapy market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Aldult CAR T-cell Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Aldult CAR T-cell Therapy Market Report

Report Metric Details
Report Name Aldult CAR T-cell Therapy Market
Segment by Type
  • CD19
  • BCMA
  • Others
Segment by Application
  • Multiple Myeloma
  • B-Cell Lymphoma (BCL)
  • Acute Lymphoblastic Leukemia (ALL)
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bristol Myers Squibb,BMS, Johnson & Johnson, Gilead Sciences, Novartis, JW Therapeutics, Imunopharm Technology Co., Ltd., CARsgen Therapeutics, Cartesian Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Aldult CAR T-cell Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Aldult CAR T-cell Therapy Market report?

Ans: The main players in the Aldult CAR T-cell Therapy Market are Bristol Myers Squibb,BMS, Johnson & Johnson, Gilead Sciences, Novartis, JW Therapeutics, Imunopharm Technology Co., Ltd., CARsgen Therapeutics, Cartesian Therapeutics

What are the Application segmentation covered in the Aldult CAR T-cell Therapy Market report?

Ans: The Applications covered in the Aldult CAR T-cell Therapy Market report are Multiple Myeloma, B-Cell Lymphoma (BCL), Acute Lymphoblastic Leukemia (ALL), Others

What are the Type segmentation covered in the Aldult CAR T-cell Therapy Market report?

Ans: The Types covered in the Aldult CAR T-cell Therapy Market report are CD19, BCMA, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Aldult CAR T-cell Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 CD19
1.2.3 BCMA
1.2.4 Others
1.3 Market by Application
1.3.1 Global Aldult CAR T-cell Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Multiple Myeloma
1.3.3 B-Cell Lymphoma (BCL)
1.3.4 Acute Lymphoblastic Leukemia (ALL)
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Aldult CAR T-cell Therapy Market Perspective (2021–2032)
2.2 Global Aldult CAR T-cell Therapy Growth Trends by Region
2.2.1 Global Aldult CAR T-cell Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Aldult CAR T-cell Therapy Historic Market Size by Region (2021–2026)
2.2.3 Aldult CAR T-cell Therapy Forecasted Market Size by Region (2027–2032)
2.3 Aldult CAR T-cell Therapy Market Dynamics
2.3.1 Aldult CAR T-cell Therapy Industry Trends
2.3.2 Aldult CAR T-cell Therapy Market Drivers
2.3.3 Aldult CAR T-cell Therapy Market Challenges
2.3.4 Aldult CAR T-cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Aldult CAR T-cell Therapy Players by Revenue
3.1.1 Global Top Aldult CAR T-cell Therapy Players by Revenue (2021–2026)
3.1.2 Global Aldult CAR T-cell Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Aldult CAR T-cell Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Aldult CAR T-cell Therapy Revenue
3.4 Global Aldult CAR T-cell Therapy Market Concentration Ratio
3.4.1 Global Aldult CAR T-cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aldult CAR T-cell Therapy Revenue in 2025
3.5 Global Key Players of Aldult CAR T-cell Therapy Head Offices and Areas Served
3.6 Global Key Players of Aldult CAR T-cell Therapy, Products and Applications
3.7 Global Key Players of Aldult CAR T-cell Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Aldult CAR T-cell Therapy Breakdown Data by Type
4.1 Global Aldult CAR T-cell Therapy Historic Market Size by Type (2021–2026)
4.2 Global Aldult CAR T-cell Therapy Forecasted Market Size by Type (2027–2032)
5 Aldult CAR T-cell Therapy Breakdown Data by Application
5.1 Global Aldult CAR T-cell Therapy Historic Market Size by Application (2021–2026)
5.2 Global Aldult CAR T-cell Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Aldult CAR T-cell Therapy Market Size (2021–2032)
6.2 North America Aldult CAR T-cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Aldult CAR T-cell Therapy Market Size by Country (2021–2026)
6.4 North America Aldult CAR T-cell Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Aldult CAR T-cell Therapy Market Size (2021–2032)
7.2 Europe Aldult CAR T-cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Aldult CAR T-cell Therapy Market Size by Country (2021–2026)
7.4 Europe Aldult CAR T-cell Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Aldult CAR T-cell Therapy Market Size (2021–2032)
8.2 Asia-Pacific Aldult CAR T-cell Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Aldult CAR T-cell Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Aldult CAR T-cell Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Aldult CAR T-cell Therapy Market Size (2021–2032)
9.2 Latin America Aldult CAR T-cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Aldult CAR T-cell Therapy Market Size by Country (2021–2026)
9.4 Latin America Aldult CAR T-cell Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Aldult CAR T-cell Therapy Market Size (2021–2032)
10.2 Middle East & Africa Aldult CAR T-cell Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Aldult CAR T-cell Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Aldult CAR T-cell Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol Myers Squibb,BMS
11.1.1 Bristol Myers Squibb,BMS Company Details
11.1.2 Bristol Myers Squibb,BMS Business Overview
11.1.3 Bristol Myers Squibb,BMS Aldult CAR T-cell Therapy Introduction
11.1.4 Bristol Myers Squibb,BMS Revenue in Aldult CAR T-cell Therapy Business (2021–2026)
11.1.5 Bristol Myers Squibb,BMS Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Aldult CAR T-cell Therapy Introduction
11.2.4 Johnson & Johnson Revenue in Aldult CAR T-cell Therapy Business (2021–2026)
11.2.5 Johnson & Johnson Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Aldult CAR T-cell Therapy Introduction
11.3.4 Gilead Sciences Revenue in Aldult CAR T-cell Therapy Business (2021–2026)
11.3.5 Gilead Sciences Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Aldult CAR T-cell Therapy Introduction
11.4.4 Novartis Revenue in Aldult CAR T-cell Therapy Business (2021–2026)
11.4.5 Novartis Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Details
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Aldult CAR T-cell Therapy Introduction
11.5.4 JW Therapeutics Revenue in Aldult CAR T-cell Therapy Business (2021–2026)
11.5.5 JW Therapeutics Recent Development
11.6 Imunopharm Technology Co., Ltd.
11.6.1 Imunopharm Technology Co., Ltd. Company Details
11.6.2 Imunopharm Technology Co., Ltd. Business Overview
11.6.3 Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Introduction
11.6.4 Imunopharm Technology Co., Ltd. Revenue in Aldult CAR T-cell Therapy Business (2021–2026)
11.6.5 Imunopharm Technology Co., Ltd. Recent Development
11.7 CARsgen Therapeutics
11.7.1 CARsgen Therapeutics Company Details
11.7.2 CARsgen Therapeutics Business Overview
11.7.3 CARsgen Therapeutics Aldult CAR T-cell Therapy Introduction
11.7.4 CARsgen Therapeutics Revenue in Aldult CAR T-cell Therapy Business (2021–2026)
11.7.5 CARsgen Therapeutics Recent Development
11.8 Cartesian Therapeutics
11.8.1 Cartesian Therapeutics Company Details
11.8.2 Cartesian Therapeutics Business Overview
11.8.3 Cartesian Therapeutics Aldult CAR T-cell Therapy Introduction
11.8.4 Cartesian Therapeutics Revenue in Aldult CAR T-cell Therapy Business (2021–2026)
11.8.5 Cartesian Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Aldult CAR T-cell Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of CD19
 Table 3. Key Players of BCMA
 Table 4. Key Players of Others
 Table 5. Global Aldult CAR T-cell Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Aldult CAR T-cell Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global Aldult CAR T-cell Therapy Market Size by Region (US$ Million), 2021–2026
 Table 8. Global Aldult CAR T-cell Therapy Market Share by Region (2021–2026)
 Table 9. Global Aldult CAR T-cell Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 10. Global Aldult CAR T-cell Therapy Market Share by Region (2027–2032)
 Table 11. Aldult CAR T-cell Therapy Market Trends
 Table 12. Aldult CAR T-cell Therapy Market Drivers
 Table 13. Aldult CAR T-cell Therapy Market Challenges
 Table 14. Aldult CAR T-cell Therapy Market Restraints
 Table 15. Global Aldult CAR T-cell Therapy Revenue by Players (US$ Million), 2021–2026
 Table 16. Global Aldult CAR T-cell Therapy Market Share by Players (2021–2026)
 Table 17. Global Top Aldult CAR T-cell Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Aldult CAR T-cell Therapy Revenue, 2025
 Table 18. Ranking of Global Top Aldult CAR T-cell Therapy Companies by Revenue (US$ Million) in 2025
 Table 19. Global 5 Largest Players Market Share by Aldult CAR T-cell Therapy Revenue (CR5 and HHI), 2021–2026
 Table 20. Global Key Players of Aldult CAR T-cell Therapy, Headquarters and Area Served
 Table 21. Global Key Players of Aldult CAR T-cell Therapy, Products and Applications
 Table 22. Global Key Players of Aldult CAR T-cell Therapy, Date of General Availability (GA)
 Table 23. Mergers and Acquisitions, Expansion Plans
 Table 24. Global Aldult CAR T-cell Therapy Market Size by Type (US$ Million), 2021–2026
 Table 25. Global Aldult CAR T-cell Therapy Revenue Market Share by Type (2021–2026)
 Table 26. Global Aldult CAR T-cell Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 27. Global Aldult CAR T-cell Therapy Revenue Market Share by Type (2027–2032)
 Table 28. Global Aldult CAR T-cell Therapy Market Size by Application (US$ Million), 2021–2026
 Table 29. Global Aldult CAR T-cell Therapy Revenue Market Share by Application (2021–2026)
 Table 30. Global Aldult CAR T-cell Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 31. Global Aldult CAR T-cell Therapy Revenue Market Share by Application (2027–2032)
 Table 32. North America Aldult CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 33. North America Aldult CAR T-cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 34. North America Aldult CAR T-cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 35. Europe Aldult CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 36. Europe Aldult CAR T-cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 37. Europe Aldult CAR T-cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 38. Asia-Pacific Aldult CAR T-cell Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 39. Asia-Pacific Aldult CAR T-cell Therapy Market Size by Region (US$ Million), 2021–2026
 Table 40. Asia-Pacific Aldult CAR T-cell Therapy Market Size by Region (US$ Million), 2027–2032
 Table 41. Latin America Aldult CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. Latin America Aldult CAR T-cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 43. Latin America Aldult CAR T-cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 44. Middle East & Africa Aldult CAR T-cell Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Middle East & Africa Aldult CAR T-cell Therapy Market Size by Country (US$ Million), 2021–2026
 Table 46. Middle East & Africa Aldult CAR T-cell Therapy Market Size by Country (US$ Million), 2027–2032
 Table 47. Bristol Myers Squibb,BMS Company Details
 Table 48. Bristol Myers Squibb,BMS Business Overview
 Table 49. Bristol Myers Squibb,BMS Aldult CAR T-cell Therapy Product
 Table 50. Bristol Myers Squibb,BMS Revenue in Aldult CAR T-cell Therapy Business (US$ Million), 2021–2026
 Table 51. Bristol Myers Squibb,BMS Recent Development
 Table 52. Johnson & Johnson Company Details
 Table 53. Johnson & Johnson Business Overview
 Table 54. Johnson & Johnson Aldult CAR T-cell Therapy Product
 Table 55. Johnson & Johnson Revenue in Aldult CAR T-cell Therapy Business (US$ Million), 2021–2026
 Table 56. Johnson & Johnson Recent Development
 Table 57. Gilead Sciences Company Details
 Table 58. Gilead Sciences Business Overview
 Table 59. Gilead Sciences Aldult CAR T-cell Therapy Product
 Table 60. Gilead Sciences Revenue in Aldult CAR T-cell Therapy Business (US$ Million), 2021–2026
 Table 61. Gilead Sciences Recent Development
 Table 62. Novartis Company Details
 Table 63. Novartis Business Overview
 Table 64. Novartis Aldult CAR T-cell Therapy Product
 Table 65. Novartis Revenue in Aldult CAR T-cell Therapy Business (US$ Million), 2021–2026
 Table 66. Novartis Recent Development
 Table 67. JW Therapeutics Company Details
 Table 68. JW Therapeutics Business Overview
 Table 69. JW Therapeutics Aldult CAR T-cell Therapy Product
 Table 70. JW Therapeutics Revenue in Aldult CAR T-cell Therapy Business (US$ Million), 2021–2026
 Table 71. JW Therapeutics Recent Development
 Table 72. Imunopharm Technology Co., Ltd. Company Details
 Table 73. Imunopharm Technology Co., Ltd. Business Overview
 Table 74. Imunopharm Technology Co., Ltd. Aldult CAR T-cell Therapy Product
 Table 75. Imunopharm Technology Co., Ltd. Revenue in Aldult CAR T-cell Therapy Business (US$ Million), 2021–2026
 Table 76. Imunopharm Technology Co., Ltd. Recent Development
 Table 77. CARsgen Therapeutics Company Details
 Table 78. CARsgen Therapeutics Business Overview
 Table 79. CARsgen Therapeutics Aldult CAR T-cell Therapy Product
 Table 80. CARsgen Therapeutics Revenue in Aldult CAR T-cell Therapy Business (US$ Million), 2021–2026
 Table 81. CARsgen Therapeutics Recent Development
 Table 82. Cartesian Therapeutics Company Details
 Table 83. Cartesian Therapeutics Business Overview
 Table 84. Cartesian Therapeutics Aldult CAR T-cell Therapy Product
 Table 85. Cartesian Therapeutics Revenue in Aldult CAR T-cell Therapy Business (US$ Million), 2021–2026
 Table 86. Cartesian Therapeutics Recent Development
 Table 87. Research Programs/Design for This Report
 Table 88. Key Data Information from Secondary Sources
 Table 89. Key Data Information from Primary Sources
 Table 90. Authors List of This Report


List of Figures
 Figure 1. Aldult CAR T-cell Therapy Picture
 Figure 2. Global Aldult CAR T-cell Therapy Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Aldult CAR T-cell Therapy Market Share by Type: 2025 vs 2032
 Figure 4. CD19 Features
 Figure 5. BCMA Features
 Figure 6. Others Features
 Figure 7. Global Aldult CAR T-cell Therapy Market Size by Application (US$ Million), 2021–2032
 Figure 8. Global Aldult CAR T-cell Therapy Market Share by Application: 2025 vs 2032
 Figure 9. Multiple Myeloma Case Studies
 Figure 10. B-Cell Lymphoma (BCL) Case Studies
 Figure 11. Acute Lymphoblastic Leukemia (ALL) Case Studies
 Figure 12. Others Case Studies
 Figure 13. Aldult CAR T-cell Therapy Report Years Considered
 Figure 14. Global Aldult CAR T-cell Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 15. Global Aldult CAR T-cell Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Aldult CAR T-cell Therapy Market Share by Region: 2025 vs 2032
 Figure 17. Global Aldult CAR T-cell Therapy Market Share by Players in 2025
 Figure 18. Global Aldult CAR T-cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 19. The Top 10 and 5 Players Market Share by Aldult CAR T-cell Therapy Revenue in 2025
 Figure 20. North America Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. North America Aldult CAR T-cell Therapy Market Share by Country (2021–2032)
 Figure 22. United States Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Canada Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Europe Aldult CAR T-cell Therapy Market Share by Country (2021–2032)
 Figure 26. Germany Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. France Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. U.K. Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Italy Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Russia Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Ireland Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Asia-Pacific Aldult CAR T-cell Therapy Market Share by Region (2021–2032)
 Figure 34. China Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Japan Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. South Korea Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Southeast Asia Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. India Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Australia & New Zealand Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Latin America Aldult CAR T-cell Therapy Market Share by Country (2021–2032)
 Figure 42. Mexico Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Brazil Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Middle East & Africa Aldult CAR T-cell Therapy Market Share by Country (2021–2032)
 Figure 46. Israel Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Saudi Arabia Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. UAE Aldult CAR T-cell Therapy Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Bristol Myers Squibb,BMS Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2021–2026)
 Figure 50. Johnson & Johnson Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2021–2026)
 Figure 51. Gilead Sciences Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2021–2026)
 Figure 52. Novartis Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2021–2026)
 Figure 53. JW Therapeutics Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2021–2026)
 Figure 54. Imunopharm Technology Co., Ltd. Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2021–2026)
 Figure 55. CARsgen Therapeutics Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2021–2026)
 Figure 56. Cartesian Therapeutics Revenue Growth Rate in Aldult CAR T-cell Therapy Business (2021–2026)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network